New research reveals that people who come off new slimming jabs like Mounjaro or Wegovy may regain shed pounds at a significantly accelerated pace than those who end conventional lifestyle plans.
Findings released in a leading health publication demonstrates that while overweight individuals frequently drop a large proportion of their total mass while undergoing treatment, the mass returns at an average rate of 0.8 kg per month after stopping.
"People buying such medications must be informed of the risk of fast weight regain when the medication ends," stated lead investigator Dr. Susan Jebb.
That rate of recovery implies a return to original weight in about 18 months.
Analyzing Treatments
The analysis, which reviewed 37 of trials involving thousands of participants, compared the outcomes of GLP-1 agonists with other pills.
The team point out that people who shed pounds through dieting usually experience a more gradual creep back—approximately 100 grams monthly—after stopping.
Understanding the Fast Rebound
Nutrition scientists believe the mechanism of the drugs accounts for the heightened rebound.
These medications mimic a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Artificially providing the hormone concentrations far above than the body's typical production might result in the system to produce less of its endogenous GLP-1, and could lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Withdrawal of this medication results in hunger is uncontrolled, making binge eating a significant risk."
An Ongoing Condition?
Medical guidelines suggest the injections for individuals with obesity-related health risks, accompanied by recommended diet and exercise modifications.
Many experts contend that, given the likelihood of relapse, the treatment should be considered long-term.
This opinion is echoed by pharmaceutical companies, who say that the findings "emphasize the persistent nature of obesity," similar to managing diseases like hypertension.
User Testimonies
Users who have come off the jabs describe a powerful return of appetite.
"It felt as if a switch flipping and you become starving," said an individual.
This challenge is worsened if individuals have not adopted sustainable lifestyle or habit changes during treatment.
Significant Use
Recent estimates indicate that millions of adults in the UK have used these injections in the past year, with interest continuing to grow.
- Adoption is more common among females compared to men.
- The 40s and 50s age group shows the highest usage rates.
- Many access the medications through private prescriptions rather than the NHS.
In conclusion, researchers stress that while these medications are powerful agents for weight loss, they are not a standalone cure and lasting health benefits hinges on combined lifestyle management.
